At week 52, the total daily insulin dose was decreased from baseline with oral semaglutide 14 mg for patients on basal, premixed and basal-bolus insulin, and were generally consistent regardless of background insulin regimen (see Fig
If you're deficient in B12, injections can increase your energy and well-being (which may lead to weight loss)
GLP-1 medicines and the treatment of obesity GLP-1RAs led to weight loss investigations, with liraglutide 3 mg daily approved for weight loss in 2014, followed by semaglutide 2.4 mg weekly in 2021, and tirzepatide in 2023
It is worth being blunt about why the more is better instinct is especially wrong for this molecule
Request your free consultation
One dose might seem fine, while the next doesnt work as expected